Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Oct 21:12:1643630.
doi: 10.3389/fmed.2025.1643630. eCollection 2025.

IgA nephropathy with monotypic IgA-κ deposits: a case report and literature review

Affiliations
Case Reports

IgA nephropathy with monotypic IgA-κ deposits: a case report and literature review

Xiao-Ying Li et al. Front Med (Lausanne). .

Abstract

IgA nephropathy (IgAN) is an immune complex-mediated glomerulonephritis characterized by predominant IgA deposition in the mesangial region, typically exhibiting polyclonal IgA deposits (co-dominance of κ and λ light chains). However, a few studies have reported IgAN cases with monotypic IgA deposition in glomeruli on renal immunofluorescence, predominantly IgA-λ, while IgA-κ deposition is rare. The pathogenesis, pathological features, and prognosis of IgA-κ monotypic deposition remain poorly understood. Here, we report a case of IgAN with monotypic IgA-κ deposits. The patient presented with microscopic hematuria and non-nephrotic range proteinuria and normal renal function. The renal histopathology revealed mild mesangial hypercellularity with segmental endocapillary proliferation. Both frozen and paraffin immunofluorescence showed monotypic IgA-κ deposition and C3 clumps deposition in mesangial region. Electron microscopy showed electron dense deposition in mesangial region, but no abnormal deposition of monoclonal light chain was observed by immunoelectron microscopy. After 12 months of follow-up, the patient was treated with maximal tolerated doses of renin-angiotensin system inhibitors combined with Nefecon, the patient's urine protein decreased significantly and renal function was stable, and no hematological disorders were found during the follow-up. Therefore, IgAN with monotypic IgA-κ deposits shares similar clinicopathological features and prognosis with IgAN with polyclonal IgA deposits, suggesting that they may belong to the same disease spectrum. Moreover, IgAN with monotypic IgA-κ deposits and proliferative glomerulonephritis with monoclonal IgA deposits (PGNMID) share similarities in pathological manifestations. Therefore, rigorous monitoring of hematological indices in IgAN patients with monotypic IgA-κ deposits is essential to remain vigilant against misdiagnosis or missed diagnosis of early-stage PGNMID.

Keywords: IgA nephropathy; case report; mesangial proliferative glomerulonephritis; monoclonal immunoglobulin; monotypic IgA-κ.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Frozen immunofluorescence (F-IF: ×400): (A) IgA: 4+, diffuse, clumpy deposition. (B) κ light chain: 4+, diffuse, globular/small mass deposition within the mesangial region. (C) λ light chain: negative. Paraffin immunofluorescence (P-IF: ×400): (D) κ light chain: 3+, diffuse, globular/ small mass deposition within the mesangial region. (E) λ light chain: negative. Immunoelectron microscope (×5,000): (F) κ light chain labeling: electron dense matter in mesangia, (+/−). (G) κ positive control. (H) λ light chain labeling: electron dense matter in mesangial region, (+/−). (I) λ positive control. Light microscopy revealed focal hypercellularity within the glomerular capillaries: (J) periodic acid-methenamine silver stain + hematoxylin-eosin stain (×200). (K) Masson’s trichrome stain (×400). (L) Periodic acid–Schiff stain (×400).
Figure 2
Figure 2
Changes in serum creatinine and urinary protein levels of patients during the follow-up period.

References

    1. Rajasekaran A, Julian BA, Rizk DV. IgA nephropathy: an interesting autoimmune kidney disease. Am J Med Sci. (2021) 361:176–94. doi: 10.1016/j.amjms.2020.10.003 - DOI - PMC - PubMed
    1. Nagae H, Tsuchimoto A, Tsuruya K, Kawahara S, Shimomura Y, Noguchi H, et al. Clinicopathological significance of monoclonal IgA deposition in patients with IgA nephropathy. Clin Exp Nephrol. (2017) 21:266–74. doi: 10.1007/s10157-016-1275-7 - DOI - PubMed
    1. Katafuchi R, Nagae H, Masutani K, Nakano T, Munakata M, Tsuruya K, et al. Clinicopathological significance of light chain deposition in IgA nephropathy. Clin Exp Nephrol. (2021) 25:621–32. doi: 10.1007/s10157-021-02026-7 - DOI - PubMed
    1. Faure GC, Tang JG, Molé C, Béné MC. Plasma cells producing lambda light chains are predominant in human gut and tonsils. An immunohistomorphometric study. Am J Clin Pathol. (1990) 94:571–5. doi: 10.1093/ajcp/94.5.571 - DOI - PubMed
    1. Suen KK, Lewis WH, Lai KN. Analysis of charge distribution of lambda- and kappa-IgA in IgA nephropathy by focused antigen capture immunoassay. Scand J Urol Nephrol. (1997) 31:289–93. doi: 10.3109/00365599709070350 - DOI - PubMed

Publication types

LinkOut - more resources